FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Cell & Gene Therapy

FUJIFILM Diosynth Biotechnologies is a CDMO Partner for Life offering end-to-end development and manufacturing solutions. They combine 30 years’ experience and technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP facilities and superior program management to advance tomorrow’s medicines.

Currently, FUJIFILM Diosynth Biotechnologies has over 4000 employees in 6 global locations. In our presentation below, Serat Ali, Director of Commercial Development, describes FUJIFILM Diosynth Biotechnologies' Advanced Therapy capabilities, discusses their global facilities network, and provides a capacity update.